trending Market Intelligence /marketintelligence/en/news-insights/trending/_nmaj0dm4titkdfki0s1vq2 content esgSubNav
In This List

Zimmer Biomet secures US FDA clearance for spinal implant system

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zimmer Biomet secures US FDA clearance for spinal implant system

The U.S. Food and Drug Administration granted 510(k) clearance to Zimmer Biomet Holdings Inc.'s spinal implant, the Zyston strut open titanium interbody spacer system.

The Warsaw, Ind.-based medical device-maker said the product is the company's first titanium spinal implant manufactured via a 3D printing process.

Zimmer said the Zyston strut open titanium system is a family of lumbar cages designed to enhance the strength, graft capacity and visualization of the interbody spacer in spinal fusion cases.